Table 2.
Study Model | Effects on AD Pathology | References |
---|---|---|
Multiple cell types (SK-N-SH, SHSY5Y, U-138, SV770, C6, PC12, N1E-115) | Decrease in soluble APP secretion in PC12, SV770, U-138, HeLa, N1E-115 | [1] |
N2a neuroblastoma cell | Protective effects against tau hyperphosphorylation induced by wortmannin | [77] |
N2a neuroblastoma cell | Protective effects against tau hyperphosphorylation induced by calyculin-A | [76] |